Esophagitis, Reflux: Clinical Trials

2 trials for Esophagitis, Reflux, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 suspended. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Suspended 1

Follow Esophagitis, Reflux: new trials by email Literature Review of Esophagitis, Reflux trials Research Report on Esophagitis, Reflux

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
To Evaluate Efficacy and Safety of Z-215 in Erosive Esophagitis
Z-215 10mg, Z-215 20mg, Z-215 Placebo - Esophagitis, Reflux
Phase 2CompletedZeria Pharmaceutical5032015-05-012017-07-02
Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis
S-Tenatoprazole-Na (STU-Na) - Esophagitis, Reflux
Phase 2SuspendedSTEBA France4502006-02-012008-03-19

Narrower conditions

Esophagitis, Peptic (2)  ·  Heartburn (1)

Broader conditions

Digestive System Diseases (2)  ·  Duodenal Diseases (2)  ·  Esophageal Diseases (2)  ·  Esophagitis (2)  ·  Gastroenteritis (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Peptic Ulcer (2)  ·  Stomach Diseases (2)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Digestive (1)

Interventions

Rabeprazole (1)

Sponsors

STEBA France (1)  ·  Zeria Pharmaceutical (1)

Countries

Canada (1)  ·  Japan (1)

Top investigators

Alan Thomson, MD, Prof. (1)